568 filings
Page 3 of 29
4
AGRX
Agile Therapeutics Inc
9 Jun 23
AGILE THERAPEUTICS / SHARON BARBARI ownership change
5:08pm
8-K
AGRX
Agile Therapeutics Inc
8 Jun 23
Submission of Matters to a Vote of Security Holders
4:35pm
8-K
AGRX
Agile Therapeutics Inc
5 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:30am
8-K
AGRX
Agile Therapeutics Inc
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
424B5
AGRX
Agile Therapeutics Inc
25 May 23
Prospectus supplement for primary offering
12:29pm
424B5
AGRX
Agile Therapeutics Inc
25 May 23
Prospectus supplement for primary offering
12:27pm
424B5
AGRX
Agile Therapeutics Inc
25 May 23
Prospectus supplement for primary offering
12:25pm
424B4
AGRX
Agile Therapeutics Inc
24 May 23
Prospectus supplement with pricing info
4:05pm
EFFECT
AGRX
Agile Therapeutics Inc
23 May 23
Notice of effectiveness
12:15am
S-1/A
AGRX
Agile Therapeutics Inc
IPO registration (amended)
19 May 23
12:20pm
CORRESP
AGRX
Agile Therapeutics Inc
19 May 23
Correspondence with SEC
12:00am
CORRESP
AGRX
Agile Therapeutics Inc
19 May 23
Correspondence with SEC
12:00am
8-K
AGRX
Agile Therapeutics Inc
17 May 23
Other Events
7:30am
10-Q
2023 Q1
AGRX
Agile Therapeutics Inc
Quarterly report
11 May 23
4:20pm
8-K
AGRX
Agile Therapeutics Inc
11 May 23
Agile Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:15pm
8-K
AGRX
Agile Therapeutics Inc
28 Apr 23
Agile Therapeutics Announces Preliminary Expectations for First Quarter 2023
4:40pm
DEF 14A
AGRX
Agile Therapeutics Inc
Definitive proxy
28 Apr 23
10:38am
ARS
2022 FY
AGRX
Agile Therapeutics Inc
28 Apr 23
Annual report to shareholders
8:21am
8-K
AGRX
Agile Therapeutics Inc
26 Apr 23
Other Events
4:59pm
UPLOAD
AGRX
Agile Therapeutics Inc
19 Apr 23
Letter from SEC
12:00am